Solara Active Pharma gets CEP of Ranitidine API restored by EDQM
Solara Active Pharma Sciences said that its certificates of suitability (CEP) for Ranitidine Hydrochloride drug substance (CEP 2001-228) has been restored by the European Directorate for the Quality of Medicines & HealthCare (EDQM). The API manufacturer said that the revised CEP was issued as of 1 July 2021. Ranitidine Hydrochloride is said to have been […]